These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8739396)

  • 41. [Pathogenetic factors of Alzheimer disease].
    Bauer J; Hüll M; Berger M
    Z Gerontol Geriatr; 1995; 28(3):155. PubMed ID: 7664189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric.
    Kumar-Singh S; Cras P; Wang R; Kros JM; van Swieten J; Lübke U; Ceuterick C; Serneels S; Vennekens K; Timmermans JP; Van Marck E; Martin JJ; van Duijn CM; Van Broeckhoven C
    Am J Pathol; 2002 Aug; 161(2):507-20. PubMed ID: 12163376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low amyloid (Abeta) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer's disease.
    Tolnay M; Calhoun M; Pham HC; Egensperger R; Probst A
    Neuropathol Appl Neurobiol; 1999 Aug; 25(4):295-305. PubMed ID: 10476046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inflammation and Alzheimer's disease pathogenesis.
    Rogers J; Webster S; Lue LF; Brachova L; Civin WH; Emmerling M; Shivers B; Walker D; McGeer P
    Neurobiol Aging; 1996; 17(5):681-6. PubMed ID: 8892340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease.
    Morris JC; Storandt M; McKeel DW; Rubin EH; Price JL; Grant EA; Berg L
    Neurology; 1996 Mar; 46(3):707-19. PubMed ID: 8618671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.
    Halliday G; Robinson SR; Shepherd C; Kril J
    Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
    Cai Z; Hussain MD; Yan LJ
    Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.
    Mrak RE; Sheng JG; Griffin WS
    J Neuropathol Exp Neurol; 1996 Mar; 55(3):273-9. PubMed ID: 8786385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology.
    Münch G; Apelt J; Rosemarie-Kientsch-Engel ; Stahl P; Lüth HJ; Schliebs R
    J Neurochem; 2003 Jul; 86(2):283-9. PubMed ID: 12871569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-1, neuroinflammation, and Alzheimer's disease.
    Mrak RE; Griffin WS
    Neurobiol Aging; 2001; 22(6):903-8. PubMed ID: 11754997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease.
    Xia M; Qin S; McNamara M; Mackay C; Hyman BT
    Am J Pathol; 1997 Apr; 150(4):1267-74. PubMed ID: 9094983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease.
    Mrak RE; Griffinbc WS
    Neurobiol Aging; 2001; 22(6):915-22. PubMed ID: 11754999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis.
    Sheng JG; Ito K; Skinner RD; Mrak RE; Rovnaghi CR; Van Eldik LJ; Griffin WS
    Neurobiol Aging; 1996; 17(5):761-6. PubMed ID: 8892349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer's disease pathogenesis.
    D'Andrea MR; Nagele RG
    Biotech Histochem; 2010 Apr; 85(2):133-47. PubMed ID: 20121465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein kinase C alteration is an early biochemical marker in Alzheimer's disease.
    Masliah E; Cole GM; Hansen LA; Mallory M; Albright T; Terry RD; Saitoh T
    J Neurosci; 1991 Sep; 11(9):2759-67. PubMed ID: 1880547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients.
    Strauss S; Bauer J; Ganter U; Jonas U; Berger M; Volk B
    Lab Invest; 1992 Feb; 66(2):223-30. PubMed ID: 1370967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing the contribution of inflammation in models of Alzheimer's disease.
    Johnston H; Boutin H; Allan SM
    Biochem Soc Trans; 2011 Aug; 39(4):886-90. PubMed ID: 21787318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic criteria for Alzheimer's disease.
    Price JL
    Neurobiol Aging; 1997; 18(4 Suppl):S67-70. PubMed ID: 9330988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microglial activation in early stages of amyloid beta protein deposition.
    Sasaki A; Yamaguchi H; Ogawa A; Sugihara S; Nakazato Y
    Acta Neuropathol; 1997 Oct; 94(4):316-22. PubMed ID: 9341931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.